Glenmark Pharmaceuticals unlocks the treatment for mild to moderate Covid-19 in India June 21, 2020 MUMBAI: In a landmark development for COVID-19 patients in India, Glenmark Pharmaceuticals announced the launch of antiviral drug Favipiravir (brand name FabiFlu) for the…